House Passes FDA Reauthorization Measure That Expands User Fees

House Passes FDA Reauthorization Measure That Expands User Fees

The legislation would raise -- by more than $2 billion from the previous five-year period -- the fees industries pay the FDA for safety and efficacy reviews. Photo: Tomohiro Ohsumi/Bloomberg